Consensus statements on vaccination in patients with haemophilia-Results from the Italian haemophilia and vaccinations (HEVA) project.


Journal

Haemophilia : the official journal of the World Federation of Hemophilia
ISSN: 1365-2516
Titre abrégé: Haemophilia
Pays: England
ID NLM: 9442916

Informations de publication

Date de publication:
Jul 2019
Historique:
received: 29 11 2018
revised: 15 03 2019
accepted: 15 03 2019
pubmed: 17 4 2019
medline: 19 12 2019
entrez: 17 4 2019
Statut: ppublish

Résumé

Vaccination against communicable diseases is crucial for disease prevention, but this practice poses challenges to healthcare professionals in patients with haemophilia. Poor knowledge of the vaccination requirements for these patients and safety concerns often result in vaccination delay or avoidance. In order to address this issue, a panel of 11 Italian haemophilia and immunization experts conducted a Delphi consensus process to identify the main concerns regarding the safe use of vaccines in patients with haemophilia. The consensus was based on a literature search of the available evidence, which was used by the experts to design 27 consensus statements. A group of clinicians then rated these statements using the 5-point Likert-type scale (1 = strongly disagree; 5 = strongly agree). The main issues identified by the expert panel included vaccination schedule for haemophilic patients; protocol and optimal route of vaccine administration; vaccination of haemophilic patients with antibodies inhibiting coagulation factor VIII (inhibitors); and vaccination and risk of inhibitor development. This manuscript discusses these controversial areas in detail supported by the available literature evidence and provides evidence- and consensus-based recommendations. Overall, participants agreed on most statements, except those addressing the potential role of vaccination in inhibitor formation. Participants agreed that patients with haemophilia should receive vaccinations according to the institutional schedule for individuals without bleeding disorders; however, vaccination of patients with haemophilia requires comprehensive planning, taking into account disease severity, type and route of vaccination, and bleeding risk. Data also suggest vaccination timing does not need to take into consideration when the patient received factor VIII replacement.

Identifiants

pubmed: 30990961
doi: 10.1111/hae.13756
pmc: PMC6850056
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

656-667

Subventions

Organisme : Sobi, Milan, Italy

Investigateurs

Chiara Ambaglio (C)
Anna Brigida Aru (A)
Erminia Baldacci (E)
Giovanni Barillari (G)
Maria Basso (M)
Sayla Bernasconi (S)
Marta Bertamino (M)
Elisa Bertoni (E)
Chiara Biasoli (C)
Eugenia Federica Biguzzi (E)
Elisa Bonetti (E)
Alessandra Borchiellini (A)
Simona Bulgarelli (S)
Sergio Cabibbo (S)
Isabella Cantori (I)
Giancarlo Castaman (G)
Paolo Castiglia (P)
Antonella Coluccia (A)
Ugo Coppetelli (U)
Antonio Coppola (A)
Dorina Cultrera (D)
Erica De Candia (E)
Grazia Delios (G)
Leonardo Di Gennaro (L)
Patrizia Di Gregorio (P)
Matteo Di Minno (M)
Alfredo Dragani (A)
Cosimo Pietro Ettorre (C)
Massimo Franchini (M)
Massimo Galli (M)
Giovanni Gallo (G)
Paola Giordano (P)
Gaetano Giuffrida (G)
Piergiorgio Iannaccaro (P)
Giuseppe Lassandro (G)
Ilaria Lazzareschi (I)
Silvia Linari (S)
Matteo Luciani (M)
Silvia Macchi (S)
Giuseppe Malcangi (G)
Raniero Malizia (R)
Marco Marietta (M)
Renato Marino (R)
Michela Massoud (M)
Maria Gabriella Mazzucconi (M)
Marta Milan (M)
Massimo Morfini (M)
Mariasanta Napolitano (M)
Samantha Pasca (S)
Paola Pedrazzi (P)
Flora A Peyvandi (FA)
Lydia Piscitelli (L)
Berardino Pollio (B)
Paola Preti (P)
Gabriele Quintavalle (G)
Paolo Radossi (P)
Simona Raso (S)
Irene Ricca (I)
Angiola Rocino (A)
Cristina Santoro (C)
Rita Carlotta Santoro (R)
Lucia Sarolo (L)
Mario Schiavoni (M)
Michele Schiavulli (M)
Patrizia Sciancalepore (P)
Maria Luisa Serino (M)
Sergio Mario Siragusa (S)
Gianluca Sottilotta (G)
Johanna Svahn (J)
Lelia Valdrè (L)
Maria Cristina Vedovati (M)
Ezio Zanon (E)

Informations de copyright

© 2019 The Authors. Haemophilia Published by John Wiley & Sons Ltd.

Références

Cochrane Database Syst Rev. 2018 Feb 01;2:CD004876
pubmed: 29388197
MMWR Recomm Rep. 2006 Dec 1;55(RR-15):1-48
pubmed: 17136024
PLoS One. 2017 Jan 6;12(1):e0169368
pubmed: 28061505
Haemophilia. 2010 Sep 1;16(5):747-66
pubmed: 20398077
HIV Med. 2008 Nov;9(10):795-848
pubmed: 18983477
Semin Thromb Hemost. 2009 Nov;35(8):723-34
pubmed: 20169509
Haemophilia. 2010 Mar;16(2):256-62
pubmed: 19878331
N Engl J Med. 2016 May 26;374(21):2054-64
pubmed: 27223147
Haemophilia. 2018 Mar;24(2):283-290
pubmed: 29243367
Haemophilia. 2019 Jul;25(4):656-667
pubmed: 30990961
AIDS. 2015 Mar 27;29(6):739-43
pubmed: 25849837
Haemophilia. 2015 Jan;21(1):e39-43
pubmed: 25381731
Blood Transfus. 2014 Oct;12(4):575-98
pubmed: 25350962
Clin Infect Dis. 2014 Feb;58(3):309-18
pubmed: 24421306
J Clin Epidemiol. 2014 Apr;67(4):401-9
pubmed: 24581294
Hum Vaccin Immunother. 2016 Nov;12(11):2729-2741
pubmed: 27409293
Philos Trans R Soc Lond B Biol Sci. 2014 May 12;369(1645):20130433
pubmed: 24821919
Haemophilia. 2009 Jul;15(4):853-63
pubmed: 19228203
J Adv Nurs. 2003 Feb;41(4):376-82
pubmed: 12581103
JAMA. 1997 Jun 4;277(21):1709-11
pubmed: 9169899
BMJ. 2000 Nov 18;321(7271):1237-8
pubmed: 11082069
Clin Infect Dis. 2018 Nov 13;67(11):1712-1719
pubmed: 29590326
PLoS One. 2018 Feb 14;13(2):e0192638
pubmed: 29444185
Vaccine. 2018 May 3;36(19):2504-2506
pubmed: 29636247
Blood. 2013 May 16;121(20):4046-55
pubmed: 23553768
J Thromb Haemost. 2011 Oct;9(10):1948-58
pubmed: 21838755
N Engl J Med. 1996 May 9;334(19):1272
pubmed: 8606735
Curr Med Chem. 2018;25(42):6070-6081
pubmed: 29773050
J Prev Med Hyg. 2013 Mar;54(1):1-10
pubmed: 24396998
HIV Med. 2012 Apr;13(4):207-18
pubmed: 22093373
Haemophilia. 2003 Sep;9(5):541-6
pubmed: 14511291
Vaccine. 2018 Mar 7;36(11):1435-1443
pubmed: 29428176
Haemophilia. 2013 May;19(3):e191-2
pubmed: 23600911
Haemophilia. 2017 Nov;23(6):904-909
pubmed: 28780770
Vaccine. 2004 May 7;22(15-16):2006-12
pubmed: 15121313
J Adv Nurs. 2000 Oct;32(4):1008-15
pubmed: 11095242
Semin Hematol. 2016 Jan;53(1):35-9
pubmed: 26805905
Haemophilia. 2017 Mar;23(2):255-263
pubmed: 28205285

Auteurs

Elena Santagostino (E)

Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico, Centro Emofilia e Trombosi Angelo Bianchi Bonomi, Milan, Italy.

Agostino Riva (A)

III Divisione di Malattie Infettive, Ospedale L. Sacco - Polo Universitario, Milan, Italy.

Simone Cesaro (S)

Pediatric Hematology Oncology, Azienda Ospedaliera Universitaria Integrata, Verona, Italy.

Susanna Esposito (S)

Department of Surgical and Biomedical Sciences, Pediatric Clinic, Università degli Studi di Perugia, Perugia, Italy.

Davide Matino (D)

Department of Experimental Medicine, Università degli Studi di Perugia, Perugia, Italy.

Renata Ilde Mazzucchelli (RI)

Swedish Orphan Biovitrum s.r.l. (Sobi), Milan, Italy.

Angelo Claudio Molinari (AC)

Thrombosis and Haemostasis Unit, Istituto Giannina Gaslini, Genoa, Italy.

Rosamaria Mura (R)

Pediatric Hematology and Oncology Unit, Ospedale Pediatrico Microcitemico, Cagliari, Italy.

Lucia Dora Notarangelo (LD)

Paediatric Onco-haematology Unit, Children's Hospital, ASST Spedali Civili, Brescia, Italy.

Annarita Tagliaferri (A)

Regional Reference Center for Inherited Bleeding Disorders, University Hospital of Parma, Parma, Italy.

Giovanni Di Minno (G)

Regional Reference Center for Coagulation Disorders, Federico II University Hospital, Naples, Italy.

Mario Clerici (M)

Department of Pathophysiology and Transplantation, Università degli Studi di Milano, Milan, Italy.
Don C Gnocchi Foundation IRCCS, Milan, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH